Mei-Chih Chen

This inventor holds 1 USPTO granted patent. Top assignee: China Medical University Hospital. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Chih Chen. Retrieved from https://idiyas.com/inventor/mei-chih-chen-vxdlcfck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mei-Chih Chen: Innovator in Biomedical Research

Introduction

Mei-Chih Chen is a prominent inventor known for her contributions to biomedical research. She has made significant strides in the field, particularly with her innovative patent that addresses critical health issues. Her work is recognized for its potential impact on therapeutic applications.

Latest Patents

Mei-Chih Chen holds a patent titled "Fusion Protein Comprising Anti-CD3 Single Domain Antibody, Exosomal Protein CD63 and RNA Binding Protein, and Uses Thereof." This patent represents her innovative approach to developing fusion proteins that could enhance therapeutic strategies in immunology.

Career Highlights

Mei-Chih Chen is affiliated with China Medical University Hospital, where she has been instrumental in advancing research initiatives. Her dedication to her work has led to significant advancements in understanding immune responses and developing novel treatment options.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Mei-Chih Chen's contributions to the field of biomedical research through her innovative patent and work at China Medical University Hospital highlight her role as a leading inventor. Her efforts continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…